Executive Summary
What this business is
Customers
Transgender and gender-diverse patients across Mexico seeking stigma-free hormone therapy, mental health, and legal care (96% domestic Mexico traffic).
Offering
Specialized transgender healthcare booking network (powered by +Clinik): lets patients compare clinician wait times (~5-day FAST mode vs. 2-month standard) for hormone therapy (THAG), backed by ~30 services (psychology, nutrition, endocrinology, voice, legal), dose calculators, job boards, and community data.
Business model
Founder-credibility-led O2O specialty clinic and clinician marketplace combining telehealth with physical clinics in Mexico City and León.
Pricing
Transparent tiered pricing: 1,250 MXN initial consult, 1,000 MXN follow-up, and sliding-scale solidarity rates as low as 350 MXN (~$20–$70 USD), payable online or in cash at Oxxo stores.
- Takeoff mode
- Clinician Community Migration
Transgender patients in Mexico historically faced months-long public waitlists, hostile providers, or unaffordable private care without bank-card access. Already trusted as an INER clinic advisor and ATLASST founder, Dra. Daniela Muñoz-Jiménez digitized her practice onto a two-doctor Google Site in Jan 2022, then removed two huge local frictions: displaying exact wait times (~5-day FAST vs. 2-month standard) and accepting 350 MXN solidarity fees via Oxxo convenience-store cash vouchers.
Charging 1,250 MXN initial / 1,000 MXN follow-up captures middle-income demand sustainably, while the 350 MXN solidarity tier acts as both social mission and viral acquisition engine—Reddit threads on r/TransgenderMX literally recommend TransSalud by citing its 300–350 MXN affordability. Once onboarded, ~30 wrap-around services (psychology, nutrition, voice therapy) compound multi-year patient LTV.
Led by Dra. Daniela Muñoz-Jiménez—founder/CEO of TranSSalud and MASS Clinik, founder of ATLASST, INER clinic advisor, and co-chair of WPATH 2026 Mexico City. Her clinical authority and community leadership create trust that outside tech startups cannot buy with ad spend.